Shine Investment Advisory Services’s Agios Pharmaceuticals AGIO Stock Holding History

Shine Investment Advisory Services’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$12K	Hold	357	–	–	﹤0.01%	521
2020 Q2	$19K	Hold	357	–	–	0.01%	460
2020 Q1	$13K	Hold	357	–	–	0.01%	479
2019 Q4	$17K	Buy	357 +169	+90%	+$6.39K	0.01%	493
2019 Q3	$6K	Hold	188	–	–	﹤0.01%	634
2019 Q2	$9K	Hold	188	–	–	﹤0.01%	545
2019 Q1	$13K	Buy	188 +106	+129%	+$6.17K	0.01%	513
2018 Q4	$4K	Hold	82	–	–	﹤0.01%	617
2018 Q3	$6K	Hold	82	–	–	﹤0.01%	581
2018 Q2	$7K	Hold	82	–	–	﹤0.01%	573
2018 Q1	$7K	Buy	+82	New	+$6.34K	﹤0.01%	571

Other funds holding AGIO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Shine Investment Advisory Services's AGIO Position: Q3 2020 in Review

Shine Investment Advisory Services held its Agios Pharmaceuticals (AGIO) position steady in Q3 2020 at 357 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

Shine Investment Advisory Services first reported a position in AGIO in Q1 2018 and has held it in 11 quarters since. The position peaked at $19K in Q2 2020. 215 funds tracked by Wall St. Rank hold AGIO as of Q3 2020.

Shine Investment Advisory Services held 357 shares of Agios Pharmaceuticals worth $12K as of Q3 2020.
Shine Investment Advisory Services left its Agios Pharmaceuticals share count unchanged in Q3 2020.
Agios Pharmaceuticals made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #521 holding.
Shine Investment Advisory Services first reported a position in Agios Pharmaceuticals in Q1 2018 and has held it in 11 quarters since.
Shine Investment Advisory Services's Agios Pharmaceuticals position peaked at $19K in Q2 2020.
215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.